Phibro Animal Health Corporation

Phibro Animal Health Corporation ( PAHC ) Q1 2027 Earnings Call November 5, 2026 9:00 AM EST Company Participants Glenn David - Chief Financial Officer Patrick Rodriguez - Vice President of Finance & Treasurer Daniel Bendheim - CEO, President & Director Larry Miller - Chief Operating Officer Conference Call Participants Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Curtis Moiles - BNP Paribas, Research Division Presentation Operator Hello, everyone. Thank you for joining us, and welcome to Phibro Animal Health Corporation to host webcast and conference call on first quarter results.

Although the revenue and EPS for Phibro (PAHC) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2026 and maintained its financial guidance for the year ending June 30, 2027. Highlights for the three months ended September 30, 2026 (compared to the three months ended September 30, 2025) Net sales of $386.8 million, an increase of $22.9 million, or 6% Net income of $29.5 million, an increase of $3.0 million, o.

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 16, 2026, to stockholders of record at the close of business on November 25, 2026. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner w.